Viewing Study NCT02698657


Ignite Creation Date: 2025-12-24 @ 6:48 PM
Ignite Modification Date: 2026-02-01 @ 2:12 PM
Study NCT ID: NCT02698657
Status: COMPLETED
Last Update Posted: 2024-10-31
First Post: 2016-02-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP5094 Following Multiple Intravenous Doses in Subjects With Rheumatoid Arthritis on Methotrexate
Sponsor: Astellas Pharma Global Development, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rheumatoid Arthritis (RA) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Rheumatoid arthritis (RA) View
None Methotrexate View
None ASP5094 View